RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Grainger, MD
Duke Clinical Research Institute
Study Chair - Cyndya Shibao, MD
Vanderbilt University Medical Center
Study Chair - Pam Taub, MD
University of California, San Diego
Study Chair - Peter Novak, MD
Harvard
Study Chair - Tae Chung, MD
Johns Hopkins University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- All Sites Listed Under Nct06305780
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2024
- Primary completion
- 23 Mar 2026
- Completion
- 1 Jul 2026
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 200
- Registry id
- NCT06305793
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.